Diffuse myocardial fibrosis (DMF) is a key process in cardiac ... DMF quantification into the clinical arena. A patient with apical hypertrophic cardiomyopathy showing the problem with the late ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

All experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham and performed in accordance with the National Institutes of ...

The best treatment strategy for patients with apical aneurysms remains unclear, and some clinicians have recommended treatment with an implantable cardioverter defibrillator or catheter ablation for ...